WATCH-TAVR
Description
LMC was one of 20 sites nationally chosen by the Cleveland Clinic. This is a randomized trial evaluating the safety and effectiveness of left atrial appendage occlusion with WATCHMAN™ Device in prevention of stroke and bleeding in patients with atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR).
Diagnosis
Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Code
NCT03173534
Accepting New Patients
Posted By: Dr. Leonardi
Posted Date: 6/2/2017
Location:
Lexington Heart and Vascular